Bausch 医疗
BHC
6.30
-0.01
-0.16%
Bausch 医疗
US · BHC
#2722 按市值排名
上市于 1970
6.30
-0.01
-0.16%
实时 - 追踪5344个代码 - 心跳于54秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例下降了0.4个百分点。
机构持股
- 机构持股比例
- 65.57% -0.39pp
- 机构数量
- 254 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Hedge Fund37.16%
Mutual Fund16.00%
Individual/Insider10.73%
Public Company5.45%
Government Pension Fund2.55%
Private Company1.98%
VC/PE Fund1.40%
Sovereign Wealth Fund0.93%
Other23.72%
主要股东 截至 2026-06-30
Paulson & Co. Inc.
19.59% · 73.26M 股
Alexander Meruelo
9.77% · 36.54M 股
GoldenTree Asset Management LP
9.27% · 34.67M 股
Vanguard Capital Management, LLC
2.60% · 9.72M 股
Healthcare of Ontario Pension Plan Trust Fund
2.14% · 8.00M 股
The Goldman Sachs Group, Inc.
1.62% · 6.07M 股
MFN Partners Management, LP
1.60% · 6.00M 股
SG Americas Securities, LLC
1.48% · 5.54M 股
Acadian Asset Management LLC
1.47% · 5.48M 股
KKR & Co. Inc.
1.40% · 5.24M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 31次买入 · 19次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Paulson & Co. Inc. | -- | 19.59% |
| Thomas Appio | Chief Executive Officer | 0.23% |
| Seana Carson | Executive Vice President | 0.19% |
| Jean-Jacques Charhon | Chief Financial Officer | 0.05% |
| Amy Wechsler | Independent Director | 0.03% |
| Christian Garcia | Independent Director | 0.02% |
| Sandra Leung | Corporate Director | 0.01% |
| Frank Lee | Independent Director | 0.01% |
| Aimee Lenar | Executive Vice President of US Pharma | 0.01% |
| Robert Power | Independent Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Sandra Leung | Corporate Director | Other Acquisition | +5,789 | $5.83 |
| 2026-09-29 | John Paulson | Independent Chairperson | Other Acquisition | +10,720 | $5.83 |
| 2026-09-29 | Amy Wechsler | Independent Director | Other Acquisition | +1,179 | $5.83 |
| 2026-08-18 | Aimee Lenar | Executive Vice President of US Pharma | Automatic Disposition | -36,827 | $7.03 |
| 2026-07-16 | Aimee Lenar | Executive Vice President of US Pharma | Sale to Issuer | -5,260 | $4.83 |
| 2026-07-14 | Aimee Lenar | Executive Vice President of US Pharma | Sale to Issuer | -23,395 | $4.89 |
| 2026-07-13 | Steven Lee | -- | Sale to Issuer | -3,125 | $4.75 |
| 2026-06-29 | Sandra Leung | Corporate Director | Other Acquisition | +6,845 | $4.93 |
| 2026-06-29 | John Paulson | Independent Chairperson | Other Acquisition | +12,677 | $4.93 |
| 2026-06-29 | Amy Wechsler | Independent Director | Other Acquisition | +1,394 | $4.93 |
| 2026-05-21 | Sandra Leung | Corporate Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | John Paulson | Independent Chairperson | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Robert Power | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Sarah Kavanagh | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Christian Garcia | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Amy Wechsler | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Eiry Roberts | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Michael Goettler | Corporate Director | Other Acquisition | +45,871 | -- |
| 2026-05-21 | Frank Lee | Independent Director | Other Acquisition | +45,871 | -- |
| 2026-05-18 | Frank Lee | Independent Director | Automatic Disposition | -24,456 | $5.43 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
Bausch 医疗 讨论区 0 条评论